| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.1M | -43.0% |
| Cost of Revenue | $4.1M | -56.4% |
| Gross Profit | $5.1M | -24.6% |
| R&D Expense | $17.3M | +61.8% |
| SG&A Expense | $10.8M | +46.1% |
| Operating Income | -$13.1M | -169.6% |
| Interest Expense | $3.9M | -38.1% |
| Pre-tax Income | -$11.9M | -1856.4% |
| Income Tax | $445K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.4M | +8665.5% |
| Accounts Receivable | $5.7M | +16.7% |
| Inventory | $3.0M | +100.3% |
| Current Assets | $17.6M | +5410.4% |
| Total Assets | $19.9M | -53.4% |
| Current Liabilities | $60.9M | +734.2% |
| Long-term Debt | $42.6M | -46.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.0M | -1056.4% |
| Capital Expenditures | $542K | +63.7% |
| Investing Cash Flow | -$542K | -100.2% |
| Financing Cash Flow | $36.5M | +111.5% |
| Free Cash Flow | -$31.5M | -947.1% |
| -67.9% |
| Net Income | -$12.4M | -520.3% |
| EPS (Basic) | -$0.30 | +68.1% |
| EPS (Diluted) | -$0.30 | +68.1% |
| Total Liabilities |
| $79.2M |
| +435.0% |
| Stockholders' Equity | -$59.3M | -309.3% |